A number of recent Congressional hearings have focused on health policy issues, including:

On September 23, the House Energy and Commerce will hold a hearing on the inactivation of dangerous pathogens in bioresearch laboratories, and on September 27 the panel will examine expanded access to investigational therapies. On September 28, the House Ways and Means Committee has scheduled a hearing on health care fraud investigations.

This article is presented for informational purposes only and is not intended to constitute legal advice.